Clinical Research Advancement

Insights & Publications | Articles

Excerpt from from the published article “Successes and Challenges in Clinical Trial Recruitment: The Experience of a New Study Team”

Recruitment and Retention in Global Clinical Research

Recruitment and retention of participants are central to the success of global clinical trials. Major multinational studies frequently experience delays or fail due to under-enrollment and poor retention, highlighting the necessity for sophisticated, globalized recruitment services.

Recruitment is Critical to The Success of Global Clinical Trials:

Direct Impact on Timelines and ROI: 86% of international clinical trials fail to meet recruitment targets within planned timelines, causing delays in drug development and increased operational costs.

Data Power and Validity: Underpowered studies due to inadequate enrollment or high dropout rates weaken results and may limit regulatory approval.

Global Diversity and Real-World Relevance: Trials lacking geographic and demographic diversity produce less generalizable findings, which can impede both regulatory success and health equity.

Why Global Recruitment Partners Are Essential

  • Access to Diverse Populations: Global recruitment partners enable targeting across regions and underserved groups, strengthening trial diversity and scientific impact.
  • Expedited Enrollment: Leveraging broad international networks and advanced technology, they accelerate participant enrollment and minimize costly delays.
  • Regulatory Expertise: They provide crucial guidance on navigating complex, region-specific regulatory requirements in multi-country clinical research.
  • Multimodal Outreach and Retention: Their expertise in digital, community, and provider engagement drives better patient participation and delivers culturally attuned support for improved retention.

Are you ready to accelerate your clinical research? Partnering with Clinical Research Advancement’s global recruitment services is the key to faster, more diverse, and highly impactful trials. By leveraging extensive networks, advanced digital tools, and in-depth local insights, we enable expedited enrollment, seamless regulatory navigation, and improved participant retention across the globe.

Collaborating with specialized global recruitment partners helps reduce costly delays, broaden patient diversity, and bring therapies to market more quickly. Now is the time to invest in strategic, scalable, and innovative solutions that drive clinical trial success.

 Let’s unlock the future of clinical research together—connect with Clinical Research Advancement’s experts today and transform your trial outcomes. (Man Hung et al., 2024).

Reference:
Man Hung, A. Mohajeri, K. Almpani, G. Carberry, J. F. Wisniewski, K. Janes, … & F. W. Licari. (2024). Successes and challenges in clinical trial recruitment: The experience of a new study team. 

Medical Sciences (Basel), 12(3), 39.

Read the full article on PMC

#ClinicalResearchAdvancement #InnovateClinicalResearch #PatientRecruitment #ClinicalTrialInnovation #TrialRetention #ResearchOpportunities

Clinical Research Advancement
Insights & Publications

Controlled Clinical Trials in Sub-Saharan Africa: A Winning Value Proposition

December 24, 2025

Persistent recruitment delays, high dropout rates, and missed timelines continue to slow global clinical trials, while data show that sub-Saharan Africa offers a largely untapped opportunity with established research capacity, large patient pools, and strong enrollment and retention performance.

Retention by Design: Operationalizing Patient-Centric Trials Without Increasing Site Burden

October 16, 2025

The quest to turn patient retention from a chronic challenge into a competitive strength—and one that benefits all stakeholders.

Optimizing Recruitment and Retention in Cancer Clinical Trials in Low-Resource Settings: Barriers and Facilitators From Nigerian Provider’s Perspectives

February 24, 2025

Authors: Babayemi O. Olakunde, PhD, MBChB, Ngozi Idemili-Aronu, PhD, Tara M. Friebel-Klingner, PhD, MPH, Adaeze Chike-Okoli, PhD, MBA, Ijeoma U. Itanyi, MD, MPH, Tonia C. Onyeka, MD, MSc, Kimberly Levinson, MD, MPH, Anne F. Rositch, PhD, MSPH, Richard B.S. Roden, PhD, Tzyy-Choou Wu, MD, PhD, and Echezona E. Ezeanolue, MD, MPH

Strategies for recruitment and retention of diverse and underserved cancer survivor and caregiver dyads in clinical trials

January 7, 2025

Cancer survivor-caregiver dyads from underrepresented racial and ethnic groups and those with lower socioeconomic status are less likely to participate in clinical research.

Oncology Clinical Trials in Africa: Partnering for Quality

April 25, 2021

Oncology clinical trials are requisite for testing the safety and effectiveness of promising treatments and deciphering new knowledge into concrete benefits for patients.

Comparison of Quality of Life and Burden of Lower Back PAIN Among Patients with and without a Diagnosis in Korea, Taiwan, JAPAN and USA

September 24, 2020

Author(s) Chen Y1, Singh SS2, Fang H3, Jung S4, Gilliam Y5, Grillo V1 1Kantar, Singapore, Singapore, 2Kantar Health, Singapore, Singapore, 3Kantar Taiwan, Taipei, Taiwan, 4Kantar, Seoul, South Korea, 5Kantar, Douglasville, Singapore

Clinical Research Advancement
Articles

Breaking Through Clinical Trial Barriers: When Recruitment Plans fail.

March 27, 2026

Many studies fall behind because initial enrollment assumptions don’t reflect real‑world patient flow, competing trials, or site capacity.

Why Africa Is the Next Big Frontier for Clinical Trials 2025–2030 Predictions

February 24, 2026

Africa is moving from “promising” to pivotal in clinical research.

Successes and Challenges in Clinical Trial Recruitment: The Experience of a New Study Team

February 10, 2026

Participant recruitment is one of the most challenging aspects of a clinical trial, directly impacting both the study’s duration and the quality of its results.

Precision, Relevance and Prediction: The Future of Clinical Trial Recruitment

January 22, 2026

The landscape of clinical trials is undergoing a profound transformation.

De-risking drug development: Ex-US clinical trials as a strategic advantage in 2025

September 9, 2025

The industry faces a significant dilemma in 2025 as it strives to maintain innovation amid growing global instability.

Improving access to innovative medicines in Africa starts with clinical trials

July 24, 2025

The global health community has long called for innovation that delivers impact where it is needed most.

Clinical Research Advancement Publications

ESMO Asia publication 2020, Annals of Oncology

ASCO GI PUBLICATION 2019_JCO

ASCO PUBLICATION 2018_JCO

“Successes and Challenges in Clinical Trial Recruitment: The Experience of a New Study Team.”

Recruitment and Retention in Global Clinical Research

Recruitment and retention of participants are central to the success of global clinical trials. Major multinational studies frequently experience delays or fail due to under-enrollment and poor retention, highlighting the necessity for sophisticated, globalized recruitment services.

Recruitment is Critical to The Success of Global Clinical Trials:

Direct Impact on Timelines and ROI: 86% of international clinical trials fail to meet recruitment targets within planned timelines, causing delays in drug development and increased operational costs.

Data Power and Validity: Underpowered studies due to inadequate enrollment or high dropout rates weaken results and may limit regulatory approval.

Global Diversity and Real-World Relevance: Trials lacking geographic and demographic diversity produce less generalizable findings, which can impede both regulatory success and health equity.

Why Global Recruitment Partners Are Essential

  • Access to Diverse Populations: Global recruitment partners enable targeting across regions and underserved groups, strengthening trial diversity and scientific impact.
  • Expedited Enrollment: Leveraging broad international networks and advanced technology, they accelerate participant enrollment and minimize costly delays.
  • Regulatory Expertise: They provide crucial guidance on navigating complex, region-specific regulatory requirements in multi-country clinical research.
  • Multimodal Outreach and Retention: Their expertise in digital, community, and provider engagement drives better patient participation and delivers culturally attuned support for improved retention.

Are you ready to accelerate your clinical research? Partnering with Clinical Research Advancement’s global recruitment services is the key to faster, more diverse, and highly impactful trials. By leveraging extensive networks, advanced digital tools, and in-depth local insights, we enable expedited enrollment, seamless regulatory navigation, and improved participant retention across the globe.

Collaborating with specialized global recruitment partners helps reduce costly delays, broaden patient diversity, and bring therapies to market more quickly. Now is the time to invest in strategic, scalable, and innovative solutions that drive clinical trial success.

 Let’s unlock the future of clinical research together—connect with Clinical Research Advancement’s experts today and transform your trial outcomes. (Man Hung et al., 2024).

Reference:
Man Hung, A. Mohajeri, K. Almpani, G. Carberry, J. F. Wisniewski, K. Janes, … & F. W. Licari. (2024). Successes and challenges in clinical trial recruitment: The experience of a new study team. 

Medical Sciences (Basel), 12(3), 39.

Read the full article on PMC